Omid Khalafi: PCT – The Platelet Parameter Almost Everyone Ignores
Omid Khalafi, Technical Support Specialist and After Sale Service Manager at Pharmateb, shared a post on LinkedIn:
“PCT (Plateletcrit): The Platelet Parameter Almost Everyone Ignores
Most clinicians routinely review Platelet Count (PLT) and occasionally MPV, but one parameter is frequently overlooked despite being automatically reported by many hematology analyzers:
Plateletcrit (PCT).
PCT represents the total circulating platelet mass, analogous to how hematocrit represents the volume occupied by red blood cells.
How is PCT calculated?
PCT (%) equals Platelet Count times MPV divided to 10,000
This means PCT reflects both:
- The number of platelets
- Their average size
As a result, two patients with identical platelet counts may have completely different platelet masses.
Why Does PCT Matter?
Looking at platelet count alone may be misleading.
For example:
Patient A
- Platelet Count: 180 ×10⁹/L
- MPV: 7.5 fL
Patient B
- Platelet Count: 180 ×10⁹/L
- MPV: 12.0 fL
Although both have the same platelet count, Patient B has a substantially higher circulating platelet mass.
PCT captures this important difference.
Clinical Applications
PCT has shown potential value in:
- Assessing platelet production and consumption
- Inflammatory diseases
- Cardiovascular disorders
- Monitoring thrombocytopenic patients
- Complementing MPV and PDW during platelet evaluation
It should never replace platelet count, but rather be interpreted together with other platelet indices.
Platelet Count tells you how many platelets are present.
MPV tells you how large they are.
PCT tells you how much platelet mass is actually circulating.
Using all three together provides a far more complete picture than relying on platelet count alone.”
Stay updated with Hemostasis Today.
-
Sep 2, 2026, 09:52Rick Matthews: Expanding Mechanical Thrombectomy to Coronary Arteries
-
Sep 2, 2026, 09:49Yara Dixon: Barriers and Facilitators to Blood Donation Across Diverse Populations
-
Sep 2, 2026, 09:29Ana Sachetto: Liver Injury and Tissue Factor-Driven Coagulation
-
Sep 2, 2026, 09:28Kavya Keerthana: A Potentially Important Advance in Polycythemia Vera
-
Sep 2, 2026, 09:26Mohammad Zuryan: Pre-Marital Genetic Screening for Thalassemia Prevention
-
Sep 2, 2026, 09:23Mohammed Salman: 9 Key Changes in the Fifth Universal Definition of Myocardial Infarction
-
Sep 2, 2026, 07:02Christoph B. Olivier: Rapid Platelet Inhibition in Acute Coronary Syndromes
-
Sep 2, 2026, 06:38Gene Therapy for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Sep 2, 2026, 06:32Sanjay Batra: Exploring What Lies Beyond Platelet Counts